Tag: clinical trials
-
NIH Begins Covid-19 Antibody Trials
National Institutes of Health is beginning clinical trials of experimental antibody therapies to treat Covid-19 infections in people with symptoms ranging from mild to severe.
-
UCLA, Apple Partner on Depression Study
Researchers from University of California in Los Angeles and Apple Corp. are beginning a study of wearable and home technologies to detect depression.
-
Trial Set for Covid-19 Antibodies in Long-Term Care
Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 infections among people in long-term care.
-
Covid-19 Vaccines, Therapies – 3 August 2020
The numbers of vaccine candidates in development and clinical trials show modest but steady growth, now up to 157 and 35 respectively.
-
Trial Underway for Seasonal Flu Antibody Therapy
A participant in an early-stage clinical trial received the first dose of an experimental synthetic antibody produced in cattle to treat seasonal influenza.
-
Trial Testing Lymphoma Drug to Treat Covid-19
A clinical trial is underway testing an experimental drug for lymphoma and neurological disorders also as a treatment for early Covid-19 infections.
-
Covid-19 Vaccines, Therapies – 27 July 2020
This week’s chart shows since last Monday more new activity for therapies than vaccines, with 15 new Covid-19 therapies joining the array of treatments in development.
-
Advanced Solid Tumor Precision Meds. Trial Begins
A clinical trial is underway testing a treatment for advanced-stage cancers that blocks amino acids allowing nutrients to feed the growth of solid tumors.
-
Trial Testing Point-of-Care Covid-19 Diagnostic
A clinical trial in the U.K. is assessing a testing device to detect Covid-19 viruses in nasal swab samples that returns results in an hour.
-
Oxford Covid-19 Vaccine Trial Invokes Immune Responses
Results from a clinical trial testing a Covid-19 vaccine show the vaccine invokes two types of immune responses without serious adverse effects.